Not every assay needs the same substrate. But every assay needs the right one.

In recent years, the country has promulgated centralized bulk-buying policy for high value medical consumables in the field of medical devices.

Spatial proteomics firm Ionpath said on Wednesday that it has received a strategic investment of undisclosed size from Thermo Fisher Scientific.

Qiagen said on Wednesday that it has acquired a 96 percent stake in Blirt, a Gdansk, Poland-based manufacturer of recombinant enzymes for the life science industry.

According to industry insiders, Mindray became the general agent of GenSure Biotech Inc., and officially started entered the SARS-CoV-2 antigen test business.

On May 10, 2022, Guangzhou LBP Medicine Science & Technology Co.,Ltd (688393.SH) and Huawei signed a cooperation agreement in Guangzhou to officially join the Ascend partner program, and also held a solution workshop on pathology data and arithmetic ecology cooperation.

Hologic announced on Tuesday that its Aptima CMV Quant assay for cytomegalovirus has been approved by the US Food and Drug Administration.

OraSure Technologies reported after the close of the market on Tuesday that its first quarter revenues increased 16 percent year over year driven by 21 percent growth in non-COVID revenues.

Recently, Bioeast Biotech announced the completion of the A+ round of financing of RMB 150 million. This round of financing was exclusively invested by LYFE CAPITAL.

Hitachi High-Tech and Invivoscribe on Monday announced a partnership to combine their expertise and technologies to develop molecular diagnostics to diagnose cancer and monitor disease during treatment.

Castle Biosciences reported after the close of the market on Monday that its first quarter revenues increased 18 percent year over year.

On May 6, BGI Genomics Co.,Ltd. announced that it will rapidly provide a comprehensive detection and screening program for children with acute hepatitis of unknown cause.